1. Introduction {#s0005}
===============

Parkinson\'s disease (PD) is associated with a progressive decline in motor control. Motor performance in PD is thought to reflect a balance between dysfunction of motor circuits, mainly due to dopamine denervation in the dorsal caudal putamen ([@bb0145]), and compensatory processes, reflecting spontaneous adaptive adjustments in the interacting neural circuits that contribute to motor control ([@bb0160], [@bb0185], [@bb0205]). Both dysfunction and compensation may be modulated by dopamine replacement therapy (DRT), the mainstay of PD treatment. The mechanisms underlying compensatory changes in PD remain unclear. It has been shown that patients may accomplish more difficult motor tasks by activating the same motor networks engaged in healthy controls, but to a greater degree and at easier stages of the task. Alternatively, or in addition, they may recruit other networks not typically recruited by healthy controls under the same conditions ([@bb0085], [@bb0205], [@bb0225]).

To date, investigations into the neural substrates of motor impairment in PD have mainly focused on alterations in cortico-striatal circuitry, detected with functional MRI or H~2~O15-PET during the performance of motor tasks. Contralateral caudal putamen and bilateral supplementary motor area (SMA) typically show diminished activation in PD patients off DRT, relative to healthy controls, during the performance of motor tasks ([@bb0250]). This is widely considered a reflection of PD pathology and is explained by the model of basal ganglia dysfunction in PD in which dopamine deficiency in the putamen leads to excessive firing of the subthalamic nucleus and globus pallidus internal segment, resulting in decreased cortical excitation, and in turn, bradykinesia.

In contrast, several studies have found that activity is enhanced in primary motor cortex (M1) ([@bb0085], [@bb0165], [@bb0220], [@bb0265], [@bb0280]) and cerebellum ([@bb0045], [@bb0165], [@bb0205], [@bb0260], [@bb0280]) in PD patients off DRT during the performance of motor tasks. The relationship of these increased activations to motor performance remains unclear, in part because of variability in both task demands and PD patient performance across studies.

The role of enhanced task-related activity in cerebellum also remains unclear. Although the cerebellum is known to play a role in motor control, it has only recently been recognized as potentially important in motor function in PD in particular ([@bb0025], [@bb0065], [@bb0175], [@bb0255]). Recent anatomical work in non-human primates has found bidirectional, disynaptic subcortical communication between the basal ganglia and cerebellum: motor regions of the dentate nucleus project via the thalamus to the sensorimotor putamen, and motor regions of the subthalamic nucleus project via the pons to cerebellar cortex, region HVIIB ([@bb0035], [@bb0105]). These findings emphasize the need to better understand striatal--cerebellar interactions in PD, in addition to the more thoroughly studied cortico-striatal circuits.

Resting state fMRI offers a different perspective on neural network changes in PD, avoiding the confounds related to differential task performance that can arise when comparing clinical and healthy populations ([@bb0070], [@bb0285]). This method has proved useful in better understanding cognitive function in PD ([@bb0010], [@bb0215]). Here, we use this approach to study network changes in relation to motor function in PD, both off and on DRT.

Studies show the putamen and M1, and the putamen and cerebellum are functionally connected at rest in healthy adults ([@bb0030], [@bb0050], [@bb0135]). To date, the effects of PD on these resting state networks remain unclear. A consensus has yet to emerge likely because of differences in disease severity or medication status across studies, and because of the small number of studies to date. For instance, putamen--cerebellum functional connectivity has been reported as decreased ([@bb0080]) or not different from healthy controls ([@bb0090]). Likewise, putamen--M1 functional connectivity has been reported as decreased ([@bb0090]), increased ([@bb0080]) or not different from healthy controls ([@bb0155]). Furthermore, the functional significance of alterations to these networks remains unknown: while DRT has been shown to relatively normalize ([@bb0270]), fully normalize ([@bb0025]), or lead to differences in motor network functional connectivity in PD compared to controls ([@bb0065]), it is unclear how these DRT-induced changes in motor network connectivity in PD relate to motor performance. Moreover, changes in functional connectivity may be viewed as deleterious (disease related) or compensatory, depending on their relationship to motor performance.

Here, we aimed to address key questions about the functional significance of the effects of mild--moderate PD on motor network functional connectivity measured with resting state fMRI in a group of patients tested off and on DRT. Given the putamen\'s core role in motor networks, and that it is the site of the most severe dopamine depletion in PD, we focused on dorsal caudal putamen functional connectivity.

First, we investigated the relationships between the strength of putamen\'s functional connectivity with M1 and cerebellum, and motor performance, assessed outside the scanner with the Purdue pegboard task in PD patients off DRT, compared to healthy controls. Second, we examined how DRT, in the form of a standard dose of levodopa, affected the strength of functional connectivity between these regions, and, how it affected the relationships between connectivity and motor performance. We confirmed the specificity of the findings by carrying out the same analyses in a control region also affected in PD, the dorsal caudate.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0025}
-----------------

Twenty-one patients with mild--moderate idiopathic Parkinson\'s disease (mean age 67, S.D. 8.9) and 20 demographically matched healthy control subjects (mean age 65, S.D. 6.7) participated in this study. Patients were recruited from the McGill University Health Centre Movement Disorders clinic. Experienced movement disorder neurologists identified patients with idiopathic PD without dementia, based on the UK brain bank criteria ([@bb0110]). All patients scored ≥ 24/30 on the Montreal Cognitive Assessment (MoCA) ([@bb0190]), a screening test for cognitive impairment. Patients with other neurological diagnoses that might affect cognition, or overt clinical depression, were excluded. Healthy controls were recruited from the local community. Controls were excluded if they had a history of neurologic or psychiatric disease, head injury, or were taking psychoactive medication. The local research ethics committee approved the study.

2.2. Study procedure {#s0030}
--------------------

All participants underwent two MRI scans in a single morning session. PD patients were scanned after an overnight (minimum 18 h) washout of their DRT (off DRT state) and again 45 min after receiving a single standard dose of Sinemet (100 mg [l]{.smallcaps}-dopa; 25 mg carbidopa) (on DRT state), timed to coincide with peak plasma concentrations ([@bb0195]). Patients continued all other medications as usual in the washout condition. Controls were not administered DRT but underwent two resting state fMRI scans, with procedures exactly the same as for the patients. The control group\'s first scan was compared to the PD group\'s first scan (off DRT), and the control group\'s second scan was compared to the PD group\'s second scan (on DRT).

2.3. Behavioral testing: motor performance {#s0035}
------------------------------------------

Patients completed the Purdue pegboard task (Lafayette Instruments, Lafayette, IN) immediately before both scans, in their DRT 'off' and 'on' states. The task requires using one hand to place as many pins as possible into the holes of a pegboard in 30 s. The score is the number of pins successfully placed. Two trials were performed with each hand (scores were averaged across trials for each hand). Higher scores signify better motor performance.

2.4. Image acquisition {#s0040}
----------------------

Imaging was carried out with a 3 T Siemens Trio scanner equipped with a standard 12-channel head coil. Foam pads were used to fix the subject\'s head within the coil to minimize head motion. A high-resolution T1-weighted magnetization-prepared rapid acquisition gradient echo (MP-RAGE) structural volume was acquired for registration purposes (TE = 2.98 ms, TR = 2300 ms, inversion time = 900 ms, flip angle = 9°, field of view = 256, voxel dimension = 1 mm isotropic). For the two resting state fMRI scans, participants were instructed to lie still with their eyes open, to think of nothing in particular and to not fall asleep. Whole-brain functional imaging was performed using a gradient echo echoplanar imaging sequence (176 volumes, TE = 30 ms, TR = 2160 ms, field of view = 256 mm, flip angle = 90°, matrix = 64 × 64, voxel dimension 4 mm isotropic, acquisition time = 6 min 22 s).

2.5. Image preprocessing {#s0045}
------------------------

Images were preprocessed and analyzed using tools from the FMRIB Software Library (FSL; [www.fmrib.ox.ac.uk/fsl](http://www.fmrib.ox.ac.uk/fsl){#ir0010}). Preprocessing included: slice time correction, motion correction (3D volume registration using least squares alignment of 3 translational and 3 rotational parameters), non-brain removal, spatial smoothing with a Gaussian 5 mm FWHM kernel, high-pass temporal filtering at 100 s and reslicing to 2 mm isotropic. Registration of high resolution structural images to the MNI152 (Montreal Neurological Institute) template was performed using FLIRT ([@bb0130], [@bb0125]). Transformation to MNI152 standard space was then further refined using FNIRT nonlinear registration ([@bb0005]).

The time series of eight nuisance variables were identified for inclusion: white matter, cerebrospinal fluid and six variable head motion parameters. To extract the covariate time series for white matter and cerebrospinal fluid, each individual\'s high-resolution structural image was segmented using FSL\'s FAST segmentation program. Segmented white matter images were thresholded at 0.95 to ensure tissue type probability. CSF and white matter images were then binarized and applied to each individual\'s 4D time series.

2.6. Functional connectivity {#s0050}
----------------------------

The sensorimotor putamen seed was an approximately spherical (radius = 1 voxel) region of interest (ROI) located in the dorsal caudal putamen (coordinates ± 28 1 3 mm in MNI152 space), consistent with previous studies ([@bb0025], [@bb0050], [@bb0135]). A seed was also placed in the dorsal caudate, as a control for the specificity of the putamen findings, at coordinates ± 13 15 9, also in line with previous studies ([@bb0025], [@bb0050], [@bb0135]).

We first extracted the ROI-associated BOLD time courses from each subject\'s 4D time series and then created subject-level whole brain maps of all voxels that were correlated with each of the ROI\'s time courses, using FEAT in FSL. Analyses of group-level functional connectivity (i.e., for HCTL runs 1 and 2, PD off, PD on) and of between group (i.e., PD vs. HCTL) and paired group comparisons (e.g., HCTL run 1 vs. run 2, PD off vs. on DRT,) were performed using FEAT\'s FLAME (FMRIB\'s Local Analysis of Mixed Effects) as implemented in FSL. Thresholded Z-score maps of putamen and caudate functional connectivity were created for each group. Direct voxelwise group/condition comparisons produced thresholded Z-score maps of those voxels showing significant differences in functional connectivity between groups or across 'off'--'on' medication conditions. For all analyses, corrections for multiple comparisons were performed at the cluster level using Gaussian random field theory (min. Z \> 2.3 cluster significance: p \< 0.05, corrected).

We tested for correlations between the strength of putamen--M1 or putamen--cerebellar functional connectivity and Purdue pegboard performance in PD patients. We focused on functional connectivity in the motor-dominant contralateral (left) hemisphere for M1 and ipsilateral (right) cerebellum in this cohort of right-handed PD patients whose symptoms were bilateral in all but one case. We extracted the mean parameter estimate values from M1 and cerebellar ROI masks (1-voxel radius spheres) that were centered on the 'PD off' group level activation maxima, from the first level analysis. As the location of maximum activation may vary between conditions (off vs. on DRT), a dispersion of coordinates up to 3 mm as per [@bb0180] was allowed between conditions to ensure within-subject consistency of anatomical areas in patients. Finally, to enable comparison of our findings to the literature, correlational analyses were performed between the strength of putamen--M1 or putamen--cerebellar functional connectivity and disease severity (UPDRS scores) or tremor scores.

3. Results {#s0015}
==========

3.1. Patient characteristics {#s0055}
----------------------------

The demographic and clinical data are shown in [Table 1](#t0005){ref-type="table"}. All participants were right handed. There were no significant differences between patients and controls with regard to age, education or estimated IQ, as assessed with the WASI--II (t tests, p*s* \> 0.05). PD patients had higher Beck Depression Inventory (BDI) scores (t(39) = 2.4, p = 0.01) compared to controls, although patients\' scores were still well below the usual thresholds for depression on this scale. Hoehn and Yahr ratings ([@bb0100]) ranged from 1.5 to 3. Motor signs were bilateral in all patients except one, whose symptoms were restricted to the right side. The severity of motor signs was rated using part III of the Unified Parkinson\'s Disease Rating Scale (UPDRS) ([@bb0060]). Individual scores were significantly lower (fewer motor signs) on DRT compared to off (t(20) = 4.73, p \< 0.001). Tremor scores were derived from the sum of UPDRS-III items 20 (tremor at rest) and 21 (action or postural tremor of hands) divided by 7 (the number of single body regions) as per [@bb0055]. The tremor scores (S.D.) were 1.1 (0.8) off DRT, and 0.7 (0.7) on DRT, and were significantly lower on DRT compared to off (t(20) = 2.12, p \< 0.05).

Seventeen patients were taking [l]{.smallcaps}-dopa/carbidopa, and 4 were taking dopamine agonists (ropinirole or pramipexole) in isolation or in combination with [l]{.smallcaps}-dopa therapy. Six patients were taking a COMT inhibitor (entacapone), 8 were taking MAO B inhibitors (rasagiline or selegiline) and 4 were taking amantadine. Additional medications included venlaflaxine and amitriptyline (in 2 patients, neither of whom were depressed at the time of testing) and trihexyphenidyl in 2 patients. All patients were on stable medication for at least 3 months before the study. When data from patients taking antidepressants or trihexyphenidyl were removed from the analyses, the patterns of results remained the same, as reported below in the full sample. Levodopa equivalent daily dose (LEDD) and dopamine agonist equivalent daily dose (DA LEDD) calculated according to [@bb9000] are shown in [Table 1](#t0005){ref-type="table"}.

3.2. Purdue pegboard performance {#s0060}
--------------------------------

With the right (dominant) hand, patients placed on average 8.9 (S.D. 2.7) pins when off DRT and 10.3 (S.D. 2.6) pins when on levodopa. With the left hand, patients placed on average 8.9 (S.D. 2.8) pins off DRT and 10.1 (S.D. 2.5) pins on levodopa. As expected, levodopa was associated with significantly improved performance for both right and left hands, within subject (paired t tests; p*s* \< 0.05). The mean improvement in pegboard performance (on--off DRT, within subject) was 1.4 (S.D. 0.8), right hand and 1.2 (S.D. 0.8), left hand. Healthy control subjects did not perform the motor task.

3.3. Head movement {#s0065}
------------------

Total head displacement did not exceed 1.2 mm in the patient group, and 1.3 mm in the healthy control group.

3.4. Functional connectivity of dorsal caudal putamen {#s0070}
-----------------------------------------------------

We assessed which brain regions were functionally connected to the dorsal caudal putamen in PD patients off and on DRT, and in healthy control subjects, over two runs, approximately 1 h apart. As expected, the putamen was functionally connected to primary and secondary motor cortical and subcortical regions, including M1, primary somatosensory cortex, and the cerebellum (lobules I--IV, V and VI), as well as prefrontal association areas ([Fig. 1](#f0005){ref-type="fig"} and Supplementary Table 1). The connectivity patterns were broadly similar in PD patients and healthy controls. Results shown are for left putamen. Results for right putamen were similar, consistent with previous studies ([@bb0050], [@bb0135], [@bb0155]).

3.5. Functional connectivity of dorsal caudate {#s0075}
----------------------------------------------

To test the specificity of the putamen findings, we carried out the identical analysis for a seed in the dorsal caudate. This seed did not show significant connectivity with motor cortex or motor lobules of the cerebellum in either group, under either condition. Instead, caudate showed connectivity with more anterior prefrontal regions, and different cerebellar regions (lobules VIIb and crus II) (Supplementary Table 2), consistent with previous studies ([@bb0050], [@bb0135], [@bb0155]). These patterns were broadly similar in PD patients and healthy controls. Results shown are for left caudate. Results for right caudate were similar.

3.6. Functional connectivity in PD patients off DRT {#s0080}
---------------------------------------------------

We compared putamen functional connectivity between PD patients withdrawn from DRT and healthy control subjects (run 1). The putamen showed significantly increased functional connectivity bilaterally with the primary motor cortex and cerebellum (lobules I--IV, V), and, ipsilaterally with the somatosensory cortex, in PD patients compared to healthy controls ([Fig. 2](#f0010){ref-type="fig"}, Supplementary Table 3). There were also regions outside the motor system showing greater functional connectivity with the putamen, including the superior temporal lobe and angular gyrus, in the PD patients (Supplementary Table 3). None of these regions were identified in the same contrast with the caudate seed (not shown). The opposite contrast did not identify any regions that showed greater putamen functional connectivity in the control group.

3.7. Effects of levodopa {#s0085}
------------------------

After a standard dose of levodopa, there were no longer any detectable differences in putamen functional connectivity between PD patients and healthy control subjects (run 2). There were no significant differences in putamen functional connectivity between run 1 and run 2 in healthy controls. PD patients showed significantly reduced functional connectivity between the putamen and cerebellum (lobules V, VI, VIIIa, VIIb) in the 'on' compared to 'off DRT' conditions, within subject. No significant effects were detected in the opposite contrast (i.e., on \> off DRT), nor did we detect an effect of levodopa on putamen--M1 functional connectivity ([Fig. 3](#f0015){ref-type="fig"} and Supplementary Table 4). The same contrasts for the caudate seed showed no significant functional connectivity changes with any of the regions identified for the putamen (not shown).

3.8. Relationship between putamen functional connectivity and motor performance {#s0090}
-------------------------------------------------------------------------------

We asked whether the increased strength of putamen--cerebellar and putamen--M1 functional connectivity observed in PD patients off DRT predicted motor performance, to understand whether these differences are pathological or compensatory. Correlation analyses were performed between pegboard performance of the right (dominant) hand and functional connectivity between the areas within right cerebellum and left M1 that showed peak connectivity with the putamen in the off DRT condition (see PD 'off' Supplementary Table 1): cerebellum, lobule V (14, − 50, − 16), and primary motor cortex (− 24, − 26, 60).

Greater functional connectivity between putamen and cerebellum (lobule V) significantly predicted *better* motor performance (pegboard scores) in PD patients off DRT (r^2^ = 0.45, p = 0.001). In contrast, greater functional connectivity between putamen and primary motor cortex significantly predicted *worse* motor performance in the same cohort (r^2^ = 0.28, p = 0.01) ([Fig. 4](#f0020){ref-type="fig"}).

3.9. Relationship between putamen functional connectivity and UPDRS scores {#s0095}
--------------------------------------------------------------------------

In keeping with the current literature, we also tested for correlations between the strength of putamen--M1 or putamen--cerebellar (lobule V) functional connectivity and disease severity (UPDRS scores) or tremor scores. We found that worse disease severity as assessed by the UPDRS score was significantly correlated with greater putamen--M1 functional connectivity in PD patients only off DRT (r^2^ = 0.27, p = 0.02), with a trend in the same direction on levodopa (r^2^ = 0.16, p = 0.07) but there was no relationship with putamen--cerebellar connectivity under either condition. Tremor scores did not predict putamen--M1 or putamen--cerebellar functional connectivity either off or on DRT (all p*s* \> 0.05).

3.10. The effect of levodopa on the relationship between functional connectivity and motor performance in PD patients {#s0100}
---------------------------------------------------------------------------------------------------------------------

We examined the relationship between motor performance and functional connectivity in the on levodopa condition, as described above for the 'off' condition. Correlations were assessed between right hand motor performance on levodopa and functional connectivity on levodopa between the putamen and regions in right cerebellum (lobule V; \[12, − 50, − 16\]) and left M1 (− 24, − 26, 62), which corresponded to those in the off DRT analyses (Supplementary Table 1).

After the administration of levodopa, although functional connectivity between putamen and cerebellum was reduced (indicated by significant leftward shift in functional connectivity from off to on DRT in [Fig. 4](#f0020){ref-type="fig"}a; asterisk in [Fig. 3](#f0015){ref-type="fig"} off \> on DRT indicates location in cerebellum), greater functional connectivity between putamen and cerebellum continued to significantly predict *better* motor performance. Similarly, as shown in [Fig. 4](#f0020){ref-type="fig"}b (PD on levodopa), after the administration of levodopa greater functional connectivity between the putamen and M1 continued to predict *poorer* motor performance (the absence of a significant left/rightward shift from off to on DRT in [Fig. 4](#f0020){ref-type="fig"}b reflects the absence of an effect of levodopa on putamen--M1 functional connectivity). There was no detectable relationship between the magnitude of the within-subject levodopa-related change in putamen--cerebellar functional connectivity and levodopa-related change in motor performance.

Finally, to further explore whether levodopa affected the relationship between putamen functional connectivity and motor performance, we ran a multiple linear regression, predicting motor performance from putamen functional connectivity, DRT condition, and their interaction. A significant interaction would indicate that functional connectivity could predict motor performance changes with DRT condition. I.e., Y = a + b(put--cerebellum) + c(put--M1) + d(DRT condition) + e(put--cerebellum ∗ DRT) + f(put--M1 ∗ DRT).

As expected, the strength of putamen--cerebellar and putamen--M1 functional connectivity, as well as DRT condition, significantly added to the prediction of motor performance (p \< 0.05). There was a trend--level interaction effect between putamen--cerebellar functional connectivity and DRT (i.e., putamen--cerebellum ∗ DRT), indicating a trend for DRT to reduce the strength of the relationship between putamen--cerebellum connectivity and motor performance. The estimated coefficient was − 0.10 (S.E. 0.05; p = 0.075). There was no significant interaction between putamen--M1 and DRT condition.

4. Discussion {#s0020}
=============

We examined the behavioral significance of changes in functional connectivity between the putamen and key motor control regions measured with resting state fMRI in a cohort of PD patients off and on DRT, relative to healthy controls. We focused our correlational analyses on two motor regions that we found were strongly connected to the dorsal caudal putamen in this cohort of patients off DRT, and that have been identified as having different motor-related activity or connectivity in PD relative to healthy controls: M1 and cerebellum. We were specifically interested in differentiating compensatory changes, which should correlate with better motor performance, from direct disease effects, which should show the opposite pattern. Motor performance was assessed with the Purdue pegboard task outside the scanner in patients off and on DRT. We chose the dorsal caudal putamen as the seed region for the connectivity analysis a priori, given this region has the greatest dopamine denervation even at the earliest stages of PD ([@bb0140], [@bb0145]) and is extensively connected with regions critical for movement.

First, we confirmed the dorsal caudal putamen is part of a functional motor network in PD patients and healthy older adults: it was functionally connected with supplementary motor area, M1 and anterior lobe of the cerebellum, replicating findings in healthy young adults ([@bb0050], [@bb0135]). This pattern of connectivity was specific to the putamen, and not observed for a seed placed in the nearby dorsal caudate, which instead demonstrated extensive connectivity with prefrontal and posterior cerebellar regions implicated in cognitive function. Then, we determined that functional connectivity between putamen and motor regions in the cerebellum ([@bb0235]) was increased in PD off DRT, relative to healthy controls, and, found this predicted better motor performance amongst the patients. Connectivity between putamen and M1 was also increased in patients, relative to healthy controls, but that increased connectivity predicted worse motor performance. Finally, we showed a standard dose of levodopa normalized functional connectivity between the putamen and cerebellum, but not between putamen and M1.

Recent studies using task-based fMRI have pointed to a role for the cerebellum in PD, reporting increased BOLD signal in the cerebellum of patients off DRT during the performance of motor tasks ([@bb0045], [@bb0120], [@bb0205], [@bb0280]). Resting state fMRI studies have also implicated the cerebellum in PD, finding increased cerebellar regional homogeneity ([@bb0270]) and increased connectivity of the cerebellum with the rest of the motor network more generally ([@bb0275]). These fMRI findings, together with recent anatomical reports of disynaptic links between the striatum and cerebellum in non-human primates ([@bb0035], [@bb0105]), suggest connectivity between the putamen and cerebellum may be of particular importance in understanding motor function in PD.

To date, only a handful of studies have examined resting state putamen functional connectivity in PD ([@bb0025], [@bb0080], [@bb0090], [@bb0155], [@bb0230]); results with respect to the cerebellum have been inconsistent. Here, increased functional connectivity between putamen and cerebellum in patients off DRT was localized to the cerebellum\'s anterior lobe, where we detected both increases in correlation strength and a more diffuse pattern of connectivity in lobules I--IV and V that extended into lobule VI, consistent with the cerebellum\'s motor topography ([@bb0075], [@bb0200], [@bb0235]). In contrast, [@bb0080] reported decreased connectivity between the posterior putamen and anterior cerebellum in advanced, medicated patients (candidates for deep brain stimulation), relative to healthy controls. In other work, [@bb0090] detected no differences in putamen--cerebellar connectivity between patients who had never been medicated (de novo) or were off DRT and healthy controls. Our finding of enhanced connectivity in the mild--moderate disease stage, together with this prior literature, raise the possibility that putamen--cerebellar connectivity in PD increases in the earlier to moderate stages of the disease, ultimately diminishing in those with severe motor symptoms. Such a pattern would be consistent with a compensatory role, eventually overwhelmed by disease progression.

The present study tested whether the observed increased functional connectivity between putamen and cerebellum was compensatory or maladaptive, by relating it to a direct measure of motor performance. We found stronger putamen--cerebellar (lobule V) connectivity in patients off DRT correlated with better motor performance, supporting a compensatory role for this striatal--cerebellar network. The only other study to date relating motor performance to cerebellar functional connectivity in PD did not report any relationship between cerebellar (lobule V)--putamen functional connectivity and motor performance, either off or on DRT. However, the authors did find that stronger functional connectivity between the two cerebellar hemispheres (lobule V) (off DRT) was associated with better motor performance in PD ([@bb0065]). Other studies have provided indirect evidence for the same claim: greater cerebellar regional homogeneity and greater degrees of cerebellar--motor network functional connectivity in general have been associated with more severe motor symptoms in PD patients with mild--moderate disease ([@bb0270], [@bb0275]).

The relationship between greater resting state putamen--cerebellar (lobule V) connectivity and better motor performance, together with this existing literature, suggest the cerebellum is increasingly engaged to carry out motor tasks made more difficult by the loss of dopamine innervation to the putamen, in line with the cerebellum\'s roles in optimizing motor control in healthy people. For instance, using positron emission tomography to measure cerebral blood flow (CBF) in healthy young adults during the early learning of timed motor sequences, [@bb0210] found that increased cerebellar CBF was linked with error correction to augment movement kinematics. Similarly, behavioral studies report patients with cerebellar lesions or degeneration display poorer motor adaptation to compensate for changing environments ([@bb0150]), poorer coordination across joints during complex tasks ([@bb0015], [@bb0245]) and decreased accuracy in the timing of movements ([@bb0115]) compared to healthy controls. This interpretation is also supported by task-related fMRI studies showing increased cerebellar activation in PD patients associated with normal task performance. Here, it is notable that functional connectivity between the putamen and cerebellum (lobule V) predicted motor performance even in the resting state. Similar observations have been made in patients recovering from stroke ([@bb0240]).

We also found that putamen--M1 functional connectivity was increased in PD patients off DRT, relative to healthy controls. Only a few resting state fMRI studies have examined the effects of PD on functional connectivity between these regions, reporting inconsistent results. Similar to our findings, [@bb0080] detected increased posterior putamen--M1 connectivity in advanced, medicated PD patients. In contrast, [@bb0090] reported decreased putamen--M1 connectivity in de novo or off DRT patients, and [@bb0155] did not detect differences in putamen--M1 connectivity in mild--moderate PD patients off DRT, relative to healthy controls. Overall, it seems disease progression and exposure to DRT lead to increased connectivity between putamen and M1. Consistent with this model, task-related fMRI BOLD signal in M1 has been shown to be decreased in early stage, never medicated PD patients ([@bb0040]), and increased in previously treated PD patients ([@bb0280]), relative to healthy controls. DRT-induced cortical re-organization has been proposed to account for the increased signal observed in M1 of previously treated patients during task performance ([@bb0040], [@bb0280]).

We found that stronger putamen--M1 connectivity was correlated with worse motor performance, whether indexed by pegboard score, or by UPDRS score, in patients off DRT, evidence that this connectivity difference reflects a pathological, maladaptive process. Similar relationships between M1 connectivity (e.g., increased regional homogeneity, increased degree of functional connectivity with the motor network in general and, increased functional connectivity with the subthalamic nucleus) and more severe disease have been reported ([@bb0020], [@bb0270], [@bb0275]). Collectively, these observations provide support for the long-held notion of dysfunctional cortico-striatal circuitry underlying motor impairments in PD.

Finally, as expected, a standard dose of levodopa significantly improved motor performance in the PD group. Levodopa also reduced putamen--cerebellar functional connectivity in PD; connectivity values fell to levels indistinguishable from healthy controls. It had no detectable effect on the maladaptive, increased putamen--M1 connectivity. The extent of the levodopa-related decrease in putamen--cerebellar functional connectivity in PD did not predict the degree of improvement in motor performance. This may have been due to the limited range of performance change measurable from off to on levodopa here: a larger levodopa dose or more sensitive motor performance measure, or both, would better address this issue. Interestingly, the levodopa-related decrease in putamen--cerebellar functional connectivity followed a 'left shift' pattern. That is, although putamen--cerebellar connectivity dropped overall on levodopa, the positive relationship between putamen--cerebellar functional connectivity and better motor performance persisted, raising the possibility that dopamine only indirectly influenced this network through its effects on motor performance. Thus, although putamen--cerebellar functional connectivity is modulated by levodopa, the compensation reflected by increased putamen--cerebellum (lobule V) functional connectivity does not seem to be directly mediated by dopamine. Rather, this connectivity may be only indirectly influenced by changes in other aspects of the motor network, dynamically contributing to optimize motor performance when needed. This may also explain why there was a tendency for the positive relationship between putamen--cerebellar connectivity and motor performance to be weaker in the 'on' levodopa condition, when compensation requirements were presumably reduced.

In this study, functional connectivity between putamen and both superior temporal gyrus (STG) and angular gyrus was increased in PD patients off DRT, relative to healthy controls. Although outside of the core motor system, these regions have shown functional connectivity with the putamen in healthy young adults at rest ([@bb0135]), and altered putamen--STG connectivity has been noted in PD. [@bb0090] previously reported decreased putamen--STG functional connectivity in de novo or off DRT patients, relative to healthy controls. This report, in conjunction with ours, suggest that disease progression leads to increased putamen--STG connectivity in PD, at least in the earlier to moderate stages of the disease. Future work could offer insight into the functional significance of these changes. The link between increased putamen--angular gyrus (BA 39) functional connectivity and PD is not immediately clear, although increased task-related fMRI BOLD signal in the angular has been linked to slower motor recovery post-stroke ([@bb0170]), suggesting that it may reflect a maladaptive process.

This study has some limitations. First, we used a standard dose of levodopa, lower than the usual dose of most of the patients in this study, presumably yielding a relatively weak manipulation of dopamine-related effects. It is notable that this manipulation nonetheless was associated with a detectable change in putamen resting state connectivity, as well as in motor performance, albeit over a limited range. The absence of a similar effect on putamen--M1 connectivity does not exclude the possibility that a higher dose or a larger sample size could lead to detectable changes in this latter network. Second, for practical reasons the design of our study confounded the DRT manipulation with scan order. We mitigated this potential problem by also scanning the control group twice over the same time frame; in controls, the connectivity measures of interest did not change across scans. This, together with the agreement of the findings with other studies, makes it unlikely that the effects we attribute to levodopa were instead related to task order. Finally, a positive correlation between amplitude of PD tremor and resting state BOLD signal has been observed in motor cortex and cerebellum ([@bb0095]). It is unlikely our findings reflect oscillatory tremor because increased putamen--cerebellar connectivity predicted better motor performance, not worse, and no correlation was detected between putamen--cerebellar functional connectivity and tremor scores. Future studies incorporating EMG measures of tremor could address this point definitively.

In conclusion, we demonstrate that mild--moderate PD is associated with enhanced putamen--M1 and putamen--cerebellar functional connectivity. The former was associated with worse motor performance, while the latter was associated with better performance, and was also reduced by administration of levodopa, consistent with engagement of a compensatory process. Together, these findings emphasize the importance of the cerebellum in offsetting the functional impact of PD-related striatal dysfunction, highlight the need to include the cerebellum in models of motor function in PD, and suggest potential novel therapeutic directions aiming to enhance cerebellar compensation.
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![Patterns of dorsal caudal putamen functional connectivity in PD patients off and on DRT and healthy control subjects over two runs, approximately 1 h apart. Maps are thresholded at a z-score \> 2.3, cluster significance: p \< 0.05, corrected for multiple comparisons. Images are displayed according to radiological convention (left is right). L, left; and R, right.](gr1){#f0005}

![Greater putamen functional connectivity in PD patients off DRT relative to healthy control subjects (min z \> 2.3; cluster significance p \< 0.05). L, left; and R, right.](gr2){#f0010}

![Regions showing significantly greater functional connectivity with putamen in PD patients off compared to on DRT (min z \> 2.3; cluster significance p \< 0.05). L, left; and R, right. A, anterior; and P, posterior.](gr3){#f0015}

![Scatter plots with best-fitting regression lines for the Purdue pegboard score as a function of (a) putamen--cerebellar functional connectivity and, (b) putamen--motor cortex functional connectivity. Data for PD off (empty circles; dashed line) and PD on (filled circles; solid line) are from the same cohort of subjects tested after overnight DRT washout ('off'), and 45 min after a standard dose of Sinemet ('on').](gr4){#f0020}

###### 

Characteristics of subjects (mean (S.D.)).

                             PD                                              HCTL
  -------------------------- ----------------------------------------------- ------------
  N                          21                                              20
  H & Y                      2.4 (0.6)                                       n/a
  Education (years)          16.1 (3.7)                                      15.8 (2.9)
  Disease duration (years)   6.6 (3.3)                                       n/a
  UPDRS                                                                      
   Off DRT                   15.3 (5.2)[⁎⁎⁎](#tf0005){ref-type="table-fn"}   n/a
   On DRT                    11.0 (4.4)                                      n/a
  LEDD (mg)                  592 (382)                                       n/a
  DA LEDD (mg)               170 (102)                                       n/a
  BDI                        6.9 (3.7)[⁎](#tf0010){ref-type="table-fn"}      2.7 (4.5)
  MoCA                       26.2 (2.1)                                      27.6 (1.3)
  IQ                         118 (8)                                         116 (4)

BDI, Beck Depression Inventory; DA, dopamine agonist; DRT, dopamine replacement therapy; H & Y, Hoehn & Yahr rating; LEDD, levodopa equivalent daily dose; MoCA, Montreal Cognitive Assessment; IQ estimated with the Wechsler Abbreviated Scale of Intelligence (WASI--II); and UPDRS, Unified Parkinson\'s Disease Rating Scale.

p \< 0.001, PD off DRT--on DRT.

p \< 0.05, PD-HCTL.
